Xianglei He

1.5k total citations · 1 hit paper
51 papers, 965 citations indexed

About

Xianglei He is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xianglei He has authored 51 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in Xianglei He's work include Cancer-related Molecular Pathways (7 papers), Renal cell carcinoma treatment (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Xianglei He is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Renal cell carcinoma treatment (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Xianglei He collaborates with scholars based in China, Germany and Ethiopia. Xianglei He's co-authors include Shaocheng Tong, Huaguang Zhang, Ming Zhao, Guoqing Ru, Shibing Wang, Xiaodong Teng, Chen Yang, Xiangmin Tong, Wen Lei and Yi Wu and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Xianglei He

49 papers receiving 952 citations

Hit Papers

A Combined Backstepping and Small-Gain Approach to Robust... 2009 2026 2014 2020 2009 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Combined Backstepping and Small-Gain Approach to Robust Adaptive Fuzzy Output Feedback Control
    2009 361 citations Xianglei He et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianglei He China 16 330 249 206 144 105 51 965
Qiang Kang China 21 69 0.2× 345 1.4× 125 0.6× 200 1.4× 111 1.1× 65 1.1k
Yuping Sun China 18 85 0.3× 301 1.2× 81 0.4× 305 2.1× 53 0.5× 56 1.2k
Ann E. Rundell United States 20 287 0.9× 470 1.9× 45 0.2× 40 0.3× 63 0.6× 68 1.3k
Paul G. O’Reilly United Kingdom 19 41 0.1× 364 1.5× 87 0.4× 286 2.0× 42 0.4× 51 1.0k
Joo‐Hoo Park South Korea 13 241 0.7× 78 0.3× 79 0.4× 27 0.2× 53 0.5× 36 610
Kazuma Sekiguchi Japan 12 237 0.7× 274 1.1× 98 0.5× 106 0.7× 6 0.1× 119 1.1k
Tomoya Mori Japan 17 89 0.3× 306 1.2× 60 0.3× 67 0.5× 37 0.4× 60 937
Cheng-Han Tsai Taiwan 12 70 0.2× 313 1.3× 78 0.4× 54 0.4× 10 0.1× 36 728
Katsuo Suzuki Japan 26 130 0.4× 761 3.1× 71 0.3× 285 2.0× 7 0.1× 83 1.7k
Lingzhi Hu China 12 138 0.4× 195 0.8× 23 0.1× 13 0.1× 155 1.5× 29 628

Countries citing papers authored by Xianglei He

Since Specialization
Citations

This map shows the geographic impact of Xianglei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglei He more than expected).

Fields of papers citing papers by Xianglei He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianglei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglei He. The network helps show where Xianglei He may publish in the future.

Co-authorship network of co-authors of Xianglei He

This figure shows the co-authorship network connecting the top 25 collaborators of Xianglei He. A scholar is included among the top collaborators of Xianglei He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianglei He. Xianglei He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Fubo, Xianglei He, Yongzhi Zhao, et al.. (2025). Liver-specific gene PGRMC1 blocks c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activation. Nature Communications. 16(1). 50–50. 4 indexed citations
2.
3.
Yang, Chen, Hui Dong, Xianglei He, et al.. (2022). The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma. Molecular Biology Reports. 49(8). 7911–7919. 14 indexed citations
4.
Zhao, Ming, Tianshi Ma, Xianglei He, & Minghua Ge. (2022). Targeted next-generation sequencing reveals activating CTNNB1 mutations in SMARCA4/BRG1-deficient sinonasal carcinomas: a report of two new cases and a brief review of the literature with an emphasis on histogenesis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(2). 453–460. 2 indexed citations
5.
He, Wei, Jin Li, Xiaolong Qi, et al.. (2021). Cavernous lymphangioma of the urinary bladder in an adult woman: an additional case report of a rare lesion and literature review. BMC Urology. 21(1). 145–145. 2 indexed citations
6.
He, Xianglei, et al.. (2021). Primary Adrenal Glomus Tumor: The First Case Report. Urologia Internationalis. 106(3). 317–320. 2 indexed citations
7.
8.
Chen, Yuan, et al.. (2021). Novel TNC-PDGFD fusion in fibrosarcomatous dermatofibrosarcoma protuberans: a case report. Diagnostic Pathology. 16(1). 63–63. 15 indexed citations
9.
Yang, Chen, Yi Wu, Guoqing Ru, et al.. (2021). Prognostic implications of cell division cycle protein 45 expression in hepatocellular carcinoma. PeerJ. 9. e10824–e10824. 7 indexed citations
10.
Zhao, Ming, Qi Zhang, Xianglei He, & Dahong Zhang. (2021). Primary Renal <b><i>BCOR-CCNB3</i></b> Fusion Sarcoma: A Case Report and Review of the Literature. Urologia Internationalis. 106(6). 644–648. 1 indexed citations
11.
Huang, Fang, et al.. (2021). Paradoxical role of interleukin-33/suppressor of tumorigenicity 2 in colorectal carcinogenesis: Progress and therapeutic potential. World Journal of Clinical Cases. 10(1). 23–34. 2 indexed citations
12.
Sun, Huimin, et al.. (2019). Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer. BMC Cancer. 19(1). 9 indexed citations
13.
14.
Jiang, Zhaoqiang, Shibo Ying, Wei Shen, et al.. (2017). Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population. Disease Markers. 2017. 1–8. 15 indexed citations
15.
Jiang, Zhaoqiang, Tianhui Chen, Junqiang Chen, et al.. (2017). Hand‐spinning chrysotile exposure and risk of malignant mesothelioma: A case–control study in Southeastern China. International Journal of Cancer. 142(3). 514–523. 18 indexed citations
16.
Ge, Yun, Wen Lei, Ying‐Yu Ma, et al.. (2017). Synergistic antitumor effects of CDK inhibitor SNS-032 and an oncolytic adenovirus co-expressing TRAIL and Smac in pancreatic cancer. Molecular Medicine Reports. 15(6). 3521–3528. 15 indexed citations
17.
Mou, Xiaozhou, Xiaoyi Chen, Guoqing Ru, et al.. (2016). High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis. OncoTargets and Therapy. 9. 3595–3595. 37 indexed citations
18.
19.
Han, Yong, Guoqing Ru, Xiaozhou Mou, et al.. (2015). AUTS2 is a potential therapeutic target for pancreatic cancer patients with liver metastases. Medical Hypotheses. 85(2). 203–206. 6 indexed citations
20.
Duan, Hongying, Ling Chen, Like Qu, et al.. (2014). Mycoplasma Hyorhinis Infection Promotes NF- κ B–Dependent Migration of Gastric Cancer Cells. Cancer Research. 74(20). 5782–5794. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiang Kang Breakdown of academic impact, for papers by Yuping Sun Breakdown of academic impact, for papers by Ann E. Rundell Breakdown of academic impact, for papers by Paul G. O’Reilly Breakdown of academic impact, for papers by Joo‐Hoo Park Breakdown of academic impact, for papers by Kazuma Sekiguchi Breakdown of academic impact, for papers by Tomoya Mori Breakdown of academic impact, for papers by Cheng-Han Tsai Breakdown of academic impact, for papers by Katsuo Suzuki Breakdown of academic impact, for papers by Lingzhi Hu
Rankless by CCL
2026